Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $432M (100.0% shares, 0.0% debt)

Holdings (25)

IVERIC BIO INC 12.5%
Value $53.79M Shares 3,217,163 Est. Cost $11.13 Unrealized
MERUS N V 11.0%
Value $47.66M Shares 1,498,890 Est. Cost $27.10 Unrealized
ACRS ACLARIS THERAPEUTICS INC 9.0%
Value $38.86M Shares 2,672,346 Est. Cost $12.93 Unrealized +17.2%
XENE XENON PHARMACEUTICALS INC 7.9%
Value $34.06M Shares 1,090,126 Est. Cost $21.69 Unrealized +37.8%
CYTK CYTOKINETICS INC 7.4%
Value $32.11M Shares 704,537 Est. Cost $24.17 Unrealized +59.6%
PTGX PROTAGONIST THERAPEUTICS INC 6.4%
Value $27.55M Shares 805,573 Est. Cost $32.91 Unrealized -3.9%
BELLUS HEALTH INC NEW 5.8%
Value $25.15M Shares 3,124,613 Est. Cost $8.05 Unrealized
COGT COGENT BIOSCIENCES INC 4.5%
Value $19.57M Shares 2,281,315 Est. Cost $9.41 Unrealized -7.6%
CYMABAY THERAPEUTICS INC 4.2%
Value $18.32M Shares 5,419,896 Est. Cost $4.48 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 3.9%
Value $16.76M Shares 847,683 Est. Cost $16.40 Unrealized +13.6%
SATSUMA PHARMACEUTICALS INC 3.9%
Value $16.7M Shares 3,711,286 Est. Cost $5.89 Unrealized
VISTAGEN THERAPEUTICS INC 3.8%
Value $16.51M Shares 8,464,999 Est. Cost $2.12 Unrealized
CCCC C4 THERAPEUTICS INC 3.6%
Value $15.49M Shares 481,094 Est. Cost $29.00 Unrealized +36.4%
CELC CELCUITY INC 2.8%
Value $12.14M Shares 920,464 Est. Cost $25.49 Unrealized -37.2%
TRICIDA INC 2.8%
Value $11.92M Shares 1,247,043 Est. Cost $9.56 Unrealized
TNYA TENAYA THERAPEUTICS INC 2.3%
Value $9.739M Shares 513,930 Est. Cost $21.49 Unrealized +1.4%
ALLAKOS INC 1.8%
Value $7.985M Shares 815,667 Est. Cost $9.79 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 1.0%
Value $4.135M Shares 312,553 Est. Cost $24.62 Unrealized -35.3%
KRONOS BIO INC 0.9%
Value $4.061M Shares 298,839 Est. Cost $29.87 Unrealized
DYN DYNE THERAPEUTICS INC 0.8%
Value $3.628M Shares 305,125 Est. Cost $19.35 Unrealized -27.4%
IVA INVENTIVA SA 0.8%
Value $3.588M Shares 262,658 Est. Cost $14.53 Unrealized
GNCAQ GENOCEA BIOSCIENCES INC 0.8%
Value $3.573M Shares 3,079,756 Est. Cost $2.51 Unrealized -40.6%
MREO MEREO BIOPHARMA GROUP PLC 0.7%
Value $3.128M Shares 1,954,970 Est. Cost $3.56 Unrealized
PMVP PMV PHARMACEUTICALS INC 0.7%
Value $2.888M Shares 125,000 Est. Cost $39.23 Unrealized -38.4%
BCLS ACQUISITION CORP 0.6%
Value $2.45M Shares 250,000 Est. Cost $11.14 Unrealized